Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Tilray Brands Inc (TLRY) vs Under Armour Inc Class A (UA) Price & Performance

Tilray Brands IncTrade
Under Armour Inc Class ATrade

Price performance (Past 24H)

Key statistics

Tilray Brands Inc vs Under Armour Inc Class A — how do they compare? Tilray Brands Inc trades at $3.61 (market cap $530.54M), while Under Armour Inc Class A trades at $4.74 (market cap $2.07B). The key difference: Under Armour Inc Class A is far larger — about 3.9× Tilray Brands Inc's market cap, and Under Armour Inc Class A is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tilray Brands Inc for 31 Days and Under Armour Inc Class A for 18 Days on average.

TLRYUA
Market Cap
$530.54M$2.07B
Volume
9,099,0752,680,141
Sector
HealthConsumer Cyclical
52-Week High
$21.00$7.88
52-Week Low
$3.57$3.96
Typical Hold Time
31 Days18 Days
Enterprise Value
$684.46M$3.05B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Tilray Brands Inc

TLRY trades at $3.715, down 1.72% on the day and near its 52-week low, reflecting persistent bearish technical momentum. The company reported revenue of $821.31M in 2025 but a substantial net loss of -$2.19B, with negative cash flow from operations. Recent quarters show consistent earnings misses versus expectations, though analyst consensus suggests a high price target of $65.01 amid mixed sentiment.

The outlook remains challenged by profitability issues and high debt, but potential catalysts include U.S. cannabis regulatory changes. Investment opportunities hinge on speculative regulatory shifts, while risks include ongoing losses, competitive pressures, and reliance on financing activities to sustain operations.

Under Armour Inc Class A

Under Armour (UA) trades at $4.70, down 0.42% with a mixed technical picture showing bullish overall signals but bearish moving averages. The company faces significant fundamental challenges with declining revenue ($5.16B in 2025 to $4.9B in 2026) and negative profitability metrics, including a -9.99% net income margin and -29.82% ROE. Recent earnings show volatility with two beats and one miss in the last four quarters, while cash flow remains negative across all categories.

The outlook remains challenging with declining revenue trends and persistent profitability issues offset by relatively low valuation multiples. Investment opportunity exists if management can stabilize sales and improve margins, but risks include continued consumer demand weakness and competitive pressures in the athletic apparel sector. Analyst sentiment is mixed with 41% buy ratings but growing concerns about the company's turnaround prospects.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TLRY
100% Buy0% Sell
Avg holding period · 31 Days
UA

No sentiment data available yet.

Top news

Latest headlines on both assets

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY →

About Under Armour Inc Class A

Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.

Read more on UA →